International Drug Development Institute SA
74.8 FTEInternational Drug Development Institute reported revenue of €11.9m for the 2025 financial year (annual accounts filed with the NBB on 16 Jun 2026), with 74.8 full-time equivalents.
By total assets for 2025, International Drug Development Institute ranks among the 10 largest of the 500 companies in its sector (NACE 8691) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of International Drug Development Institute shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue -20 % Equity +515 % Total assets +204 % Headcount (avg FTE) -21 %
Accounts of the company itself (not consolidated).
The full file covers 11 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
International Drug Development Institute's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €11.9m | ||||
| Net result | −€1.13m | ||||
| Equity | €21.0m | ||||
| Cash | €1.35m | ||||
| EBITDA | −€1.88m | ||||
| Total assets | €28.5m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 16 Jun 2026
- Year ended 31 Dec 2024filed on 13 Jun 2025
- Year ended 31 Dec 2023filed on 14 Jun 2024
- Year ended 31 Dec 2022filed on 20 Jun 2023
- Year ended 31 Dec 2021filed on 14 Jun 2022
International Drug Development Institute's financial analysis
- Solvency73.7%sector median: 66.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of International Drug Development Institute
2 active director(s) in the register.
International Drug Development Institute's shareholders and holdings →International Drug Development Institute's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0436.264.032
- VAT number
- BE0436264032
- Peppol
- Registered · 0208:0436264032 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 26 Dec 1988
- Registered office
- 1341 Ottignies-Louvain-la-Neuve
- Size
- Medium · 74.8 FTE
- Latest accounts
- 2025 · filed on 16 Jun 2026
- Activity
- Diagnostic imaging services and medical laboratory activities (NACE 86910)
International Drug Development Institute (SA) has been based in Ottignies-Louvain-la-Neuve since 1988, active in: diagnostic imaging services and medical laboratory activities. For 2025, it reports revenue of €11.9m, a net loss of €1.13m and equity of €21.0m. With 74.8 full-time equivalents, it is a medium-sized enterprise by headcount. Its solvency stands at 73.7%, above the median of its sector (66.2%).
Guide: Checking a Belgian supplier invoice: numbers and IBAN →
Companies similar to International Drug Development Institute
Companies in the same business, of comparable size and area, outside its group.
- Namsa Belgium Manufacture of basic pharmaceutical products Diest · balance sheet €41.5m
- Laboratoire de l'Institut Medical Specialise Diagnostic imaging services and medical laboratory activities Ottignies-Louvain-la-Neuve · balance sheet €22.3m
- CluePoints Retail sale of pharmaceutical products Ottignies-Louvain-la-Neuve · balance sheet €33.2m
- Enovalife Computer consultancy and computer facilities management activities Evere · balance sheet €21.9m
- Syneos Health Belgium Research and experimental development on natural sciences and engineering Brussels · balance sheet €8.53m
- Estetra Research and experimental development on natural sciences and engineering Liège · balance sheet €66.6m
- Talen Activities of holding companies Antwerp · balance sheet €10.2m
- Iqvia RDS & Integrated Services Belgium Business and other management consultancy activities Zaventem · balance sheet €47.5m
Frequently asked questions about International Drug Development Institute
What is the revenue of International Drug Development Institute?
According to the 2025 annual accounts filed with the NBB, the revenue of International Drug Development Institute amounts to 11,894,916 €.
What is the VAT number of International Drug Development Institute?
In Belgium, the VAT number is the company number prefixed with BE: BE0436264032 for International Drug Development Institute, if the company is VAT-registered. Its company number (CBE) is 0436.264.032.
Where is the registered office of International Drug Development Institute?
According to the CBE register, the registered office of International Drug Development Institute is in 1341 Ottignies-Louvain-la-Neuve.
What is the equity of International Drug Development Institute?
At the close of the 2025 financial year, the equity of International Drug Development Institute amounts to 20,992,696 €, a solvency of 73.7% of total assets.
How many people work at International Drug Development Institute?
74.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages International Drug Development Institute?
The register lists 2 active mandates at International Drug Development Institute. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is International Drug Development Institute within its sector?
By total assets for 2025, International Drug Development Institute ranks among the 10 largest of the 500 companies in its sector (NACE 8691) in Belgium that filed accounts for that financial year.
The full file of International Drug Development Institute
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →